glp-1 insulin secretion Schematic of action of on JCI - New ways in

Patients taking insulin or sulfonylureas alongside GLP-1 receptor agonists should monitor their blood glucose more frequently during the first week, as the combination can increase the risk of hypoglycaemia

These benefits likely result from improved endothelial function, reduced inflammation, better glycemic control, and enhanced cardiovascular health rather than direct drug effects on sexual physiology

Patients on GLP-1 programs such as semaglutide or tirzepatide sometimes use it as a complementary metabolic support injection

Diabetes Care 33 , 24092415 (2010)

For the treatment of disease, there is a lack of evidence-based research to support the use of most isolated fiber types